Assessing Immunovant (IMVT) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Immunovant, Inc. (IMVT)
Company Research
Source: Yahoo! Finance
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Immunovant in Context: Recent Performance Snapshot Immunovant (IMVT) has been under pressure recently, with the stock showing a 2.3% decline over the past day and weaker returns over the week, month, and past 3 months, despite a stronger 1 year gain. See our latest analysis for Immunovant. At a share price of US$24.41, Immunovant has seen short term share price pressure, including a 7 day share price return of negative 8.44%. In contrast, longer term total shareholder returns, such as the 1 year total shareholder return of 25.05% and 3 year total shareholder return of 57.48%, reflect a very different experience for investors. If Immunovant has you thinking about where growth and risk might look different in biotech, it could be worth scanning 33 healthcare AI stocks as a starting list of ideas. So with Immunovant sitting at US$24.41, recent share price w
Show less
Read more
Impact Snapshot
Event Time:
IMVT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMVT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMVT alerts
High impacting Immunovant, Inc. news events
Weekly update
A roundup of the hottest topics
IMVT
News
- Immunovant (IMVT) is now covered by Sanford C. Bernstein. They set a "market perform" rating and a $28.00 price target on the stock.MarketBeat
- Immunovant Stock Up 30% as Investor Trims Stake by $3 Million, But Here's Why It Still Seems Bullish [Yahoo! Finance]Yahoo! Finance
- Immunovant, Inc. (IMVT) Analysts Raise Price Targets Following Q3 Earnings Update [Yahoo! Finance]Yahoo! Finance
- Assessing Immunovant (IMVT) Valuation As Shares Deliver A 25% One Year Return [Yahoo! Finance]Yahoo! Finance
- SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Immunovant, Inc. (NASDAQ: IMVT)PR Newswire
IMVT
Earnings
- 2/6/26 - Beat
IMVT
Sec Filings
- 3/20/26 - Form 4
- 2/27/26 - Form 4
- 2/10/26 - Form 144
- IMVT's page on the SEC website